South Korea Bans Novartis Drugs Over Kickbacks

Source: Reuters

Mar 03, 2017

South Korea's Ministry of Food and Drug Safety has fined Novartis $174,937 and temporarily banned sales of some of its drugs for paying kickbacks to doctors.

The ministry placed a fine on 30 drug items and banned sales of 12 variations of 3 drug types including Alzheimer's drug Exelon for three months, reported Reuters. The sales ban will be effective from March 17 through June 16.

Read the Reuters article